granisetron has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piccioni, AL | 1 |
| Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K | 1 |
2 other study(ies) available for granisetron and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
[Out-patient management of nausea and vomiting in multiday therapy of acute myeloid leukemia in the elderly. Use of granisetron in slow-release transdermal formulation. Clinical case].
Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Delayed-Action Preparations; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Middle Aged; Nausea; Quality of Life; Vomiting | 2019 |
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult | 2012 |